Schedule 13G ownership disclosure
TG THERAPEUTICS INC COM
Security class unavailable · CUSIP: 88322Q108
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,046,598
- Percent of class
- 2.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-001654
- Form type
- SC 13G
- Filer
- Darwin Global Management, Ltd.
- CIK
- CIK 1839209
- Filed
- Feb 14, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership